UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008486
Receipt number R000009968
Scientific Title Multicenter prospective cohort study of remission induction and maintainance effects of anti-TNFagents for Crohn's jejunoileitis.
Date of disclosure of the study information 2012/07/20
Last modified on 2023/10/08 22:32:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter prospective cohort study of remission induction and maintainance effects of anti-TNFagents for Crohn's jejunoileitis.

Acronym

Effects of Anti-TNFagents for Crohn's jejunoileitis.

Scientific Title

Multicenter prospective cohort study of remission induction and maintainance effects of anti-TNFagents for Crohn's jejunoileitis.

Scientific Title:Acronym

Effects of Anti-TNFagents for Crohn's jejunoileitis.

Region

Japan


Condition

Condition

Suspected and documented Cron's jejunoileitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

There have been few reports regarding drug effects for Crohn's jejunoileitis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes of enteroscopic findings

Key secondary outcomes

CDAI, IOIBD, CRP, Adverse events of anti-TNF agents and patency capsule endoscopy, etc.


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Infliximab

Interventions/Control_2

Adalimumab

Interventions/Control_3

Immunomodulator

Interventions/Control_4

Diet therapy

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with susupected or documented Crohn's jejunoileitis

Key exclusion criteria

Contraindications of anti-TNF agents

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidemi Goto

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

65 Tsuruma-cho, Showa-ku, Nagoya

TEL

052-744-2172

Email

hgoto@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Ohmiya

Organization

Fujita Health University School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi

TEL

0562-93-9240

Homepage URL


Email

nohmiya@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine, Department of Gastroenterology and Hepatology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

豊橋市民病院(愛知県)、名古屋医療センター(愛知県)、江南厚生病院(愛知県)、刈谷豊田総合病院(愛知県)、小牧市民病院(愛知県)、一宮市民病院(愛知県)、岡崎市民病院(愛知県)、海南病院(愛知県)、上飯田第一病院(愛知県)、公立陶生病院(愛知県)、トヨタ記念病院(愛知県)、豊田厚生病院(愛知県)、半田市立半田病院(愛知県)、ブラザー記念病院(愛知県)、八千代病院(愛知県)、山下病院(愛知県)、


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 09 Month 12 Day

Date of IRB

2012 Year 09 Month 12 Day

Anticipated trial start date

2012 Year 09 Month 25 Day

Last follow-up date

2015 Year 09 Month 30 Day

Date of closure to data entry

2015 Year 10 Month 01 Day

Date trial data considered complete

2015 Year 10 Month 10 Day

Date analysis concluded

2015 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 07 Month 20 Day

Last modified on

2023 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009968


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name